D-0163-2019 Class II Terminated
FDA drug recall D-0163-2019 was initiated by Pharm D Solutions, LLC on Sep 10, 2018 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 114 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 7, 2018
- Initiation Date
- Sep 10, 2018
- Termination Date
- Feb 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 114 vials
Product description
HCG 50,000 unit/0.3 gm Mannitol Lyophilized Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1736-50
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide
Code information
Lot: 04092018:36 Discard by: 10/6/2018; 05292018:93 Discard by: 11/25/2018; 08062018:96 Discard by: 2/2/2019; 07022018:64 Discard by: 7/6/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0163-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026